Warning for Counterfeit Insulin Pens

Health Care Inspectorate Warns of Counterfeit Insulin Needles

Products counterfeited: Insulin needles Lot numbers: 08J02S
Countries known affected: Netherlands, UK, Poland Investigating agency contact: Inspectie Voor de Gezondheidszorg
Manufacturers information: Novo Nordisk Posted on/updated: July 2009

View Larger Map

The Netherlands Health Care Inspectorate [Inspectie voor de Gezondheidszorg (IGZ)] has issued a public warning following the discovery of counterfeit needles for insulin delivery systems (insulin pens). Use of these needles could present a health risk. It is known that some 200,000 counterfeit needles have been introduced to the Netherlands, of which 30,000 remain unaccounted for and may still be in circulation.

A Dutch company purchased 2,000 packs of needles (with 100 needles in each pack) from a wholesaler in Malaysia. The wholesaler claims that the needles derive from Iran. The supply line cannot be traced beyond this point. The Health Care Inspectorate continues to investigate the matter.

Some 200,000 counterfeit needles were released onto the Dutch market, a further 500,000 in the United Kingdom and over 1.3 million in Poland. A total of over two million counterfeit needles have therefore found their way into the regular European distribution channels.

Novo Nordisk B.V., the licensed distributor of genuine NovoFine® insulin needles in the Netherlands, received a patient complaint stating that a recently purchased needle did not fit properly onto the insulin delivery pen. Novo Nordisk submitted a large quantity of needles to its parent company in Denmark for inspection. It was determined that the needles were counterfeit, whereupon the manufacturer reported to matter to the appropriate authority, the Netherlands Health Care Inspectorate.

The Inspectorate advises any users who are unsure of the origins of their needles to contact their pharmacist or supplier. All information about the current situation can be found on the manufacturer's website at www.novonordisk.nl.

The Health Care Inspectorate consulted the Royal Dutch Association for the Advancement of Pharmacy (KNMP) prior to issuing this press release. The Association informed its members of the situation on Friday, June 19.

How Can Users Identify a Counterfeit Needle?

Risks

Use of the counterfeit needles presents a number of risks. The needle could break off during use. The needle may not fit onto the insulin delivery pen properly, whereupon insulin is not administered in the correct dosage. It is not known whether the counterfeit needles have been thoroughly sterilised: they could cause discomfort, skin irritation or infections.

The Netherlands Health Care Inspectorate has informed the relevant authorities in all European member states and is also to contact the World Health Organization (WHO).

|


Want to get a summary of global counterfeit drug news emailed to you every week? Sign up for our email list!

 Email:


New Rogues Gallery Comics Available

The 5 Secrets Canadian Web Pharmacies Don't Want You To Know
Learn the secrets!


Report Counterfeit and Black Market Medicines

Track & Trace legislation
President Obama signed into law, on November 27, 2013, legislation to enhance the safety of the drug supply chain, which has seen a number of incidents in recent years threaten American patients.   Learn more>>


Get Breaking News

 

Youtube  Follow Us on Twitter Like us on Facebook Flickr Delicious Stumble Upon Tumblr

Drug Safety Alert

Regeneca Worldwide, A Division Of Vivaceuticals, Inc Voluntarily Recalls RegeneSlim Appetite Control Capsules Due To The Presence Of DMAA That May Pose Possible Health Risk (August 8)

counterfeit drug alerts to tweet Tweet this alert!

Counterfeit Drug Incident Encyclopedia

counterfeit drug incident encyclopedia banner